2nd At-Home Rapid COVID Test , Is Authorized by the FDA.<br />The U.S. Food and Drug Administration (FDA) announced its authorization on Dec. 28.<br />The test was designed by Siemens Healthineers and can now be used in addition to the Roche test the FDA also recently approved.<br />The authorization comes as test shortages have wracked the nation amid record-breaking numbers of infections.<br />Officials with the <br />Biden administration praised <br />the FDA's move as in keeping <br />with its COVID priorities.<br />Increasing Americans' access to easy-to-use, reliable COVID <br />tests is a top priority for the <br />Biden Administration, , Xavier Becerra, Health and Human Services Secretary, via 'The Hill'.<br />... and we are using all resources at our disposal to make more tests available and ramp up supply, Xavier Becerra, Health and Human Services Secretary, via 'The Hill'.<br />With daily infections topping 300,000 in the U.S., at-home testing has become a signature administration strategy.<br />Adding two new authorized tests will give Americans more options for testing at home, , Xavier Becerra, Health and Human Services Secretary, via 'The Hill'.<br />... which helps keep people safe and provides peace of mind, Xavier Becerra, Health and Human Services Secretary, via 'The Hill'.<br />FDA officials cautioned <br />that the at-home test is <br />not 100 percent accurate.<br />Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. , Jacqueline A. O’Shaughnessy, FDA Scientist, <br />via 'The Hill'.<br />Despite this, the tests <br />offer reliable guidance <br />in the context of a person's<br />potential exposure to COVID-19.<br />Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, Jacqueline A. O’Shaughnessy, FDA Scientist, <br />via 'The Hill'.<br />The Biden administration is expected to begin distribution of 500 million at-home tests sometime in January
